CN105725194A - 一种破膜裸藻胶囊及其制备方法 - Google Patents
一种破膜裸藻胶囊及其制备方法 Download PDFInfo
- Publication number
- CN105725194A CN105725194A CN201610093796.9A CN201610093796A CN105725194A CN 105725194 A CN105725194 A CN 105725194A CN 201610093796 A CN201610093796 A CN 201610093796A CN 105725194 A CN105725194 A CN 105725194A
- Authority
- CN
- China
- Prior art keywords
- euglena
- membranes
- rupture
- vitamin
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000195620 Euglena Species 0.000 title claims abstract description 79
- 239000002775 capsule Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000012528 membrane Substances 0.000 claims abstract description 43
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 27
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 16
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 16
- 239000011718 vitamin C Substances 0.000 claims abstract description 16
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 11
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 11
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 11
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 11
- 239000001168 astaxanthin Substances 0.000 claims abstract description 11
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- 238000004140 cleaning Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 238000007796 conventional method Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000011010 flushing procedure Methods 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 239000008399 tap water Substances 0.000 claims description 4
- 235000020679 tap water Nutrition 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- -1 selenocarrageenan Chemical compound 0.000 claims description 2
- 239000011669 selenium Substances 0.000 abstract description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 229910052711 selenium Inorganic materials 0.000 abstract description 4
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 210000000170 cell membrane Anatomy 0.000 abstract description 3
- 235000006708 antioxidants Nutrition 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 230000008821 health effect Effects 0.000 abstract description 2
- 230000009471 action Effects 0.000 abstract 1
- 229940113118 carrageenan Drugs 0.000 abstract 1
- 235000010418 carrageenan Nutrition 0.000 abstract 1
- 229920001525 carrageenan Polymers 0.000 abstract 1
- 239000000679 carrageenan Substances 0.000 abstract 1
- 230000007123 defense Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007246 mechanism Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 150000003346 selenoethers Chemical class 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 abstract 1
- RHAXKFFKGZJUOE-UHFFFAOYSA-N 7-acetyl-6-ethyl-3,5,8-trihydroxy-9,10-dioxoanthracene-1,2-dicarboxylic acid Chemical compound O=C1C2=CC(O)=C(C(O)=O)C(C(O)=O)=C2C(=O)C2=C1C(O)=C(CC)C(C(C)=O)=C2O RHAXKFFKGZJUOE-UHFFFAOYSA-N 0.000 description 5
- 230000003064 anti-oxidating effect Effects 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1626—Selenium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/712—Vitamin E
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种裸藻胶囊及其制备方法，包括下列重量的组分：维生素C 2?5g、虾青素1?2g、维生素E 0.5?1g、硒化卡拉胶0.5?1.0g，用破膜裸藻干粉补充至总量为50.0g。制备方法，包括下列步骤：A、清洗；B、破膜；C、干燥；D、添加；E灌装。本发明的裸藻胶囊增强了裸藻对机体的健康效应，特别是抗氧化功能，其中硒和维生素E是细胞膜上作用机制不相同的一对抗氧化剂，再加上中药的协同作用，完善和提高了细胞膜对氧化损伤的防御能力，本发明的制备方法具有工艺简便、提高效率、增强功效，增加效益等诸多优点。
Description
技术领域
本发明涉及一种破膜裸藻胶囊的制备方法，属于精细化工保健品领域。
背景技术
裸藻是一种没有细胞壁的单细胞生物，是同时具有植物和动物两种特征的微细胞藻类。
众多研究报道裸藻富含人体所必需的维生素、矿物质、蛋白质、脂类、碳水化物等多种营养素和生物活性物质，具有抗氧化、降血脂、降血糖和抗肿瘤等多种生物学功效。在天然裸藻所含有的矿物质中，硒含量相对较低。目前国内外厂家生产的破膜裸藻干粉，是采用将裸藻脱水干燥后再研磨成粉末的工艺制备而成。在破膜裸藻干粉的制备过程中，维生素C损失率较高,因此破膜裸藻干粉及其制品中的维生素C含量也相对较少。硒是谷胱苷肽过氧化酶的组成部分，对维持细胞膜的正常结构和功能、提高体内的内源性抗氧化剂产量起着极其重要的作用，具有抗氧化、抗衰老、抗肿瘤和保护心血管等作用。维生素C是人体的重要营养素，具有抗氧化、抗衰老、抗坏血病、抗肿瘤、增强免疫力等生理功能。破膜裸藻干粉及其制品中硒和维生素C含量不足，必将影响裸藻产品的营养保健作用,对其抗氧化、清除自由基、抗肿瘤、抗衰老等生物学作用产生不利影响。
天然裸藻无细胞壁，裸露的细胞内容物是由一层浆膜包裹，细胞内外的物质交换也是通过该层浆膜进行的。生物体要消化吸收裸藻细胞的内容物，首先要消化破坏该层浆膜。该层浆膜由蛋白、脂类和糖类等多种物质组成，干燥后稳定性极强，在人体胃肠道中消化速率很低，并会因此而影响对裸藻细胞内营养物质的吸收。然而，目前采用将裸藻直接干燥制成的破膜裸藻干粉，每一个裸藻细胞内的物质都背包绕在该干燥后的浆膜内，必将影响到裸藻及其制品的生物学功效。
本发明依据包绕裸藻细胞内容物的该层浆膜对弱酸不太稳定的特性，先将新鲜裸藻采用弱酸进行破膜，使细胞内容物溢出，再进行干燥并制成该破膜裸藻干粉的基础上，加入适量的硒化卡拉胶、虾青素和维生素C，从而增加了破膜裸藻干粉及其制品的消化吸收及其抗氧化活性、抗衰老等诸多生物学功效，弥补了目前裸藻及其制品存在的不足，扩展了应用领域。
发明内容
本发明所要解决的技术问题是：提供一种破膜裸藻胶囊及其制备方法。
为解决上述技术问题，本发明采用的技术方案是：
本发明提供的裸藻胶囊，包括下列重量的组分：维生素C 2-5g、虾青素1-2g、维生素E 0.5-1g、硒化卡拉胶0.5-1.0g，用破膜裸藻干粉补充至总量为50.0g，制成总计100粒胶囊,每粒胶囊含量为0.5 g。
本发明还提供一种裸藻胶囊的制备方法，包括下列步骤：
A、清洗：将裸藻先用自来水反复清洗，去掉杂物，再用蒸馏水冲洗至无色清澈后滤干并收集裸藻。
B、破膜：将上述收集的裸藻置于适量PH值为6.5-6.7的微酸溶液中浸泡2-3小时，溶液温度约为35-40℃，使其溶解破膜后用碳酸氢钠溶液调节PH值为7.0-7.1。
C、干燥：采用常用喷雾干燥的方法将上述裸藻液制成破膜裸藻干粉。
D、添加：分别取虾青素、硒化卡拉胶、维生素E和维生素C充分混匀后，加入上述破膜裸藻干粉中并充分混匀。
E灌装：将上述混合均匀的混合破膜裸藻干粉用常规方法装入胶囊壳内，制成裸藻胶囊。每个胶囊内容物的重量为0.5g。
本发明的有益效果：
本发明将新鲜的裸藻经清洗、破膜、干燥等工艺制成破膜裸藻粉，再增加适量硒，维生素C、虾青素后制备成破膜裸藻胶囊的方法，增强了破膜裸藻干粉对机体的健康效应，特别是抗氧化功能、营养补充作用和消化吸收水平。本发明的制备方法具有工艺简便、提高效率、易于消化吸收、增强功效，增加效益等诸多优点。
具体实施方式
实施例1
本实施例提供的裸藻胶囊，包括下列重量的组分：维生素C 2g、虾青素1g、维生素E 0.5g、硒化卡拉胶0.5g，用破膜裸藻干粉补充至总量为50.0g，制成总计100粒胶囊，每粒胶囊含量为0.5 g。
破膜裸藻胶囊的制备方法，包括下列步骤：
A、清洗：将将裸藻先用自来水反复清洗，去掉杂物，再用蒸馏水冲洗至无色清澈后滤干并收集裸藻。
B、破膜：将上述收集的裸藻置于适量PH值为6.5的微酸溶液中浸泡2小时，溶液温度为40℃，使其溶解破膜后用碳酸氢钠溶液调节PH值为7.0。
C、干燥：采用常用喷雾干燥的方法将上述裸藻液制成破膜裸藻干粉
D、添加：分别取维生素C 2g、虾青素1g、维生素E 0.5g、硒化卡拉胶0.5g充分混匀，再加入上述破膜裸藻干粉至总量为50g，并充分混合均匀；
D、灌装：将上述混合均匀的混合破膜裸藻干粉用常规方法装入胶囊壳内，制成裸藻胶囊。每个胶囊内容物的重量为0.5g，总计100粒胶囊。
实施例2
本实施例提供的裸藻胶囊，包括下列重量的组分：维生素C 3g、虾青素2g、维生素E 1g、硒化卡拉胶1g，用破膜裸藻干粉补充至总量为50g。制成总计100粒胶囊，每粒胶囊含量为0.5 g。
裸藻胶囊的制备方法，包括下列步骤：
A、清洗：将裸藻先用自来水反复清洗，去掉杂物，再用蒸馏水冲洗至无色清澈后滤干并收集裸藻。
B、破膜：将上述收集的裸藻置于适量PH值为6.7的微酸溶液中浸泡3小时，溶液温度为35℃，使其溶解破膜后用碳酸氢钠溶液调节PH值为7.1。
C、干燥：采用常用喷雾干燥的方法将上述裸藻液制成破膜裸藻干粉。
D、添加：分别取维生素C 3g、虾青素2g、维生素E 1g、硒化卡拉胶1g充分混匀，再加入上述破膜裸藻干粉至总量为50g，并充分混合均匀。
D、灌装：将上述混合均匀的混合破膜裸藻干粉用常规方法装入胶囊壳内，制成裸藻胶囊。每个胶囊内容物的重量为0.5g，总计100粒胶囊。
经动物小鼠喂养实验证明，每摄入100克本胶囊中内容物(其中含蛋白和多糖分别为33克和42克),粪便中蛋白和多糖分别为4克和11克,吸收率分别为87.88%和73.81%。对照样品(目前市售裸藻胶囊)则为每100克胶囊内容物含蛋白和多糖分别为32克和43克,吸收率分别为63.2%和51.7%。本发明蛋白和多糖的吸收率均较对照样品高20%以上。
Claims (2)
1. 一种破膜裸藻胶囊，其特征在于，包括下列重量的组分：维生素C 2-5g、虾青素1-2g、维生素E 0.5-1g、硒化卡拉胶0.5-1.0g，用破膜裸藻干粉补充至总量为50.0g。
2. 制备上述权利要求1所述的破膜裸藻胶囊的方法，其特征在于，包括下列步骤
A、清洗：将裸藻先用自来水反复清洗，去掉杂物，再用蒸馏水冲洗至无色清澈后滤干并收集裸藻；
B、破膜：将上述收集的裸藻置于PH值为6.5-6.7的微酸溶液中浸泡2-3小时，溶液温度为35-40℃，使其溶解破膜后用碳酸氢钠溶液调节PH值为7.0-7.1；
C、干燥：采用常用喷雾干燥的方法将上述裸藻液制成破膜裸藻干粉；
D、添加：分别取虾青素、硒化卡拉胶、维生素E和维生素C充分混匀后，加入上述破膜裸藻干粉中并充分混匀；
E灌装：将上述混合均匀的混合破膜裸藻干粉用常规方法装入胶囊壳内，制成裸藻胶囊；每个胶囊内容物的重量为0.5g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610093796.9A CN105725194B (zh) | 2016-02-22 | 2016-02-22 | 一种破膜裸藻胶囊及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610093796.9A CN105725194B (zh) | 2016-02-22 | 2016-02-22 | 一种破膜裸藻胶囊及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105725194A true CN105725194A (zh) | 2016-07-06 |
| CN105725194B CN105725194B (zh) | 2019-06-11 |
Family
ID=56245419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610093796.9A Expired - Fee Related CN105725194B (zh) | 2016-02-22 | 2016-02-22 | 一种破膜裸藻胶囊及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105725194B (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60196157A (ja) * | 1984-03-16 | 1985-10-04 | Amano Pharmaceut Co Ltd | ユ−グレナ含有食品 |
| JPH02265458A (ja) * | 1989-04-04 | 1990-10-30 | Nikken Food Kk | 老化制御食品 |
| JP2011184592A (ja) * | 2010-03-09 | 2011-09-22 | Euglena Co Ltd | アモルファスパラミロン |
| CN104522828A (zh) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | 一种藻类酵素保健固体饮品及其制备工艺 |
| CN104605340A (zh) * | 2014-12-10 | 2015-05-13 | 黑龙江众生生物工程有限公司 | 一种裸藻口服液及其生产方法 |
| CN104997824A (zh) * | 2015-08-04 | 2015-10-28 | 陈志高 | 一种眼虫藻保健药、眼虫藻保健胶囊及其制备方法 |
-
2016
- 2016-02-22 CN CN201610093796.9A patent/CN105725194B/zh not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60196157A (ja) * | 1984-03-16 | 1985-10-04 | Amano Pharmaceut Co Ltd | ユ−グレナ含有食品 |
| JPH02265458A (ja) * | 1989-04-04 | 1990-10-30 | Nikken Food Kk | 老化制御食品 |
| JP2011184592A (ja) * | 2010-03-09 | 2011-09-22 | Euglena Co Ltd | アモルファスパラミロン |
| CN104605340A (zh) * | 2014-12-10 | 2015-05-13 | 黑龙江众生生物工程有限公司 | 一种裸藻口服液及其生产方法 |
| CN104522828A (zh) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | 一种藻类酵素保健固体饮品及其制备工艺 |
| CN104997824A (zh) * | 2015-08-04 | 2015-10-28 | 陈志高 | 一种眼虫藻保健药、眼虫藻保健胶囊及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105725194B (zh) | 2019-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102308997B (zh) | 一种植物酵素及其制备方法 | |
| CN101828744B (zh) | 抗疲劳、提高免疫力的全营养高活性海参饮液及其制法 | |
| CN104187946A (zh) | 一种水果植物酵素饮料及其制备方法 | |
| CN102160646A (zh) | 一种天然食品添加剂 | |
| CN105028993B (zh) | 一种鲟鱼雌鱼特制软颗粒饲料及其制备方法 | |
| CN110074194A (zh) | 一种航天用健脑功能性全豆豆浆及其制备方法 | |
| CN108601372A (zh) | 用于宠物的协同有效的抗氧化剂组合物 | |
| Ishiaq et al. | Bio-nutritional constituents of coconut fruit and its possible medicinal applications | |
| CN103710237A (zh) | 一种蜂产品酒及其制备方法 | |
| CN107997005A (zh) | 一种玉米浸泡新工艺制备玉米胚芽的方法 | |
| CN110433231A (zh) | 调节内分泌、补气血、祛皱美白、抗衰老胶囊及其制备方法 | |
| CN108684819A (zh) | 一种青少年果蔬乳品饮料及其制备方法 | |
| KR20170036886A (ko) | 배, 석세포 및 딸기를 이용한 음료의 제조방법 | |
| CN101623061B (zh) | 一种利用鲜蜂皇胎和蜂粮制备保健营养液的方法 | |
| CN204245062U (zh) | 一种甜菜碱粉剂 | |
| CN105725194A (zh) | 一种破膜裸藻胶囊及其制备方法 | |
| CN101223966A (zh) | 猕猴桃系列食品的制备方法 | |
| CN102640934A (zh) | 制备含α-亚麻酸、卵磷脂、维生素E、可溶性膳食纤维素的营养粉的方法 | |
| CN105249465A (zh) | 一种提高免疫力的保健食品及其制备方法 | |
| JP2011062140A (ja) | 梅干しの製造方法及び梅干し | |
| TWI520688B (zh) | A low-nucleic acid yeast composition, a method for producing the same, and a weight loss composition comprising the low-nucleic acid yeast | |
| CN104054912A (zh) | 利用提取甜菜碱盐酸盐后剩余母液生产甜菜碱粉剂的方法 | |
| KR20210017474A (ko) | 노니를 이용한 반려동물용 젤리형 영양보조제의 제조방법 | |
| CN109846050A (zh) | 一种抗衰老的复方小分子肽功能食品及其制备方法 | |
| Wei et al. | Improvement effect of enzymic polypeptide from Paeonia ostii seed meal on protein-energy malnutrition mouse model |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190611 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |